Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11760786
Chimeric antigen receptors targeting abnormal glycobiology
granted -
US 11759427
Formation of stable submicron peptide or protein particles by thin film freezing
granted -
US 11759453
SHMT inhibitors
granted -
US 11760764
Methods and compositions for targeting PD-L1
granted -
US 11761006
Use of MIR101 or MIR128 in the treatment of seizure disorders
granted -
CA 3244873
TRAITEMENT PRÉVENTIF DE LA MIGRAINE
granted -
US 11753627
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
granted -
US 11753381
Inhibitors of receptor interacting protein kinase I for the treatment of disease
granted -
US 11753444
Modulation of structured polypeptide specificity
granted -
US 11753655
Compositions and methods for treatment of neurological disorders
granted -
US 11753366
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted -
US 11752190
Modulators of complement activity
granted -
US 11753447
Cyclic peptides, methods of synthesis, and methods of treatment
granted -
US 11753474
Anti-Dectin-2 antibodies
granted -
US 11753644
Compounds and methods for reducing IFNAR1 expression
granted -
US 11753628
HSD17B13 variants and uses thereof
granted -
US 11753623
Compositions for treating retinal diseases and methods for making and using them
granted -
US 11753630
Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene
granted -
US 11753466
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof
granted -
US 11752106
Pharmaceutical composition and administrations thereof
granted -
US 11753443
Conjugated hepcidin mimetics
granted -
US 11753459
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11753461
Optimized factor VIII genes
granted -
US 11753408
Compounds and method for blocking transmission of malarial parasite
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.